Chimeric antagonist anth1

Details for Australian Patent Application No. 2003223832 (hide)

Owner Centro de Ingenieria Genetica y Biotecnologia

Inventors Torres Ruiz, Yeny; Penton Roll, Giselle; Bello Rivero, Iraldo; Lopez Saura, Pedro; Blanco Garces, Elizabeth

Agent Shelston IP

Pub. Number AU-B-2003223832

PCT Number PCT/CU03/00006

PCT Pub. Number WO2003/095488

Priority CU2002/0095 10.05.02 CU

Filing date 8 May 2003

Wipo publication date 24 November 2003

Acceptance publication date 19 February 2009

International Classifications

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

C07K 14/57 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 15/23 (2006.01) Mutation or genetic engineering

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): CU2002/0095 10.05.02 CU

15 January 2004 Application Open to Public Inspection

  Published as AU-B-2003223832

19 February 2009 Application Accepted

  Published as AU-B-2003223832

11 June 2009 Corrigenda

  Applications OPI - Name Index Under the Name Centro de Ingenieria Genetica y Biotecnologia, Application No. 2003223832, under INID (43) correct the Publication Date to read 24 November 2003

18 June 2009 Standard Patent Sealed

2 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003223833-METHOD FOR RE-ROUTING A COMMUNICATION LINK INCLUDING SEVERAL RADIO COMMUNICATION SYSTEMS

2003223831-Specific antibody fragments for the human carcinoembryonic antigen (CEA)